Top compounds associated with response to CRYGS


Feature Type Standardized
Nominal ANOVA
mRNA silmitasertib CTRPv2 pan-cancer AAC 0.08 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.04
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.078 0.04
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.068 0.04
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.065 0.04
mRNA KU-55933 GDSC1000 pan-cancer AAC 0.076 0.04
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.15 0.04
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.062 0.05
mRNA XL-184 GDSC1000 pan-cancer AAC 0.072 0.05
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.063 0.05
Download CSV